Quarter Financials

Aeglea BioTherapeutics, Inc. (AGLE)

$0.128

-0.00 (-3.03%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Net Income -19-18-22-24-20-20-7-18
Dividend Paid --------
Retained Earnings -426-407-389-366-342-321-301-294

PPE Schedule

Year 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Capital Expenditure --0--0--0-0-0
Net PPE 778889910

Intangible and Goodwill Schedule

Year 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
New Purchases -24-69-26-13-4-24-7-5
Intangible and Goodwill --------